Biotech

All Articles

' Clinical instinct' led FDA experts to back Zevra's unusual ailment med

.Zevra Rehabs' unusual illness drug seems to be to become on the path to authorization this loss aft...

Pfizer takes $230M struck after axing fell short DMD genetics treatment

.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) gene treatment failure has blown a $230 thousand...

AC Immune sees 'spots' possible in Alzheimer's drug information

.After greater than twenty years of focus on neurodegenerative diseases, Swiss biotech air condition...

GSK loses ph. 2 HPV vaccine over lack of best-in-class possible

.GSK has scrapped a stage 2 individual papillomavirus (HPV) injection from its own pipe after decidi...

OS Treatments refiles $6M IPO to fund HER2 medication, preclinical ADCs

.Operating system Therapies will definitely note on the NYSE American inventory exchange today via a...

ALX's waning CD47 feedback price sends out inventory spiraling down

.ALX Oncology's stage 2 gastric cancer response fee has diminished. After observing its own CD47 blo...

Ionis axes eye condition coming from intendeds of Roche-partnered possibility after information dissatisfy

.Another of Ionis Pharmaceuticals' crucial midphase readouts has actually disappointed desires, cuin...

Biogen's CEO stated no high-risk deals in 2023. He prepares to become strong

.While Biogen's pharma peers are actually looking for late-stage possessions along with little risk,...

Instil refills pipe in $2B biobucks cope with ImmunOnco

.Instil Biography has been actually a biotech in search of a pipeline after it ditched its lead poss...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually restored civil rights to a very early Alzheimer's disease system to Denali Ther...